All Infectious Disease articles – Page 15
-
NewsDisney princesses face hidden health risks, including zoonotic infections, warn experts
Although Disney princesses seem to live happily ever after, they face serious real world health hazards, warn experts in the Christmas edition of the BMJ.
-
NewsStaphylococcus aureus thwarts vaccines by turning on a protein that halts immune response
Approximately 30 clinical trials to date have failed to result in an effective human vaccine for Staphylococcus aureus but researchers have now identified a key reason for these failures, indicating that it may be possible to modify the vaccines to work in humans.
-
NewsDeadly mould strains highly likely to acquire resistance to new drugs
Scientists have identified strains of one of the world’s most dangerous fungal pathogens, already resistant to our most effective antifungal drugs, which are also five times more likely to acquire resistance to desperately needed new treatments in development. Source: Ufficio Comunicazione, Azienda Ospedaliera SS. Antonio e ...
-
NewsRoyal Veterinary College awarded international grants to advance research into cattle vaccines
The Royal Veterinary College (RVC) has been awarded two pump-prime grants from the International Veterinary Vaccinology Network (IVVN) to advance crucial research into Bovine Babesiosis and Bovine Tuberculosis vaccines to support cattle welfare.
-
NewsFrom Yemen to Mayotte, the spread of a highly drug-resistant cholera strain
Scientists have revealed the spread of a highly drug-resistant cholera strain. The strain is resistant to ten antibiotics – including azithromycin and ciprofloxacin, two of the three recommended for treating cholera – and was identified for the first time in Yemen in 2018-2019.
-
NewsFlu virus remains infectious in refrigerated raw milk
Influenza or flu virus can remain infectious in refrigerated raw milk for up to five days, a new study reveals. The findings come at a time when outbreaks of bird flu in dairy cattle have raised concerns about the potential for a new pandemic.
-
NewsGlobal research uncovers critical weakness in malaria parasite
Scientists exploring how immunity develops against Plasmodium falciparum found that broadly reactive antibodies from various individuals consistently bound to the same site on a key virulence protein of the malaria parasite.
-
FeaturesMicrobiome research and a paradigm shift in urban building design
There is increasing evidence that this association between a host and its microbes not only determines health and disease but also influences the behaviour of humans and other animals.
-
NewsFederal needle exchange programs are cost-effective to reduce health care costs, blood-borne infections
Needle exchange programs are evidence-based strategies that prevent transmission of blood-borne viruses, reduce injection-related infections, improve access to medical care, and facilitate entry into substance dependence programs for people who inject drugs, says a new study.
-
NewsBreakthrough of the Year: A drug that prevents HIV infection, providing six months of protection per shot
As its 2024 Breakthrough of The Year, Science has named the development of lenacapavir – a promising new injectable drug that prevents HIV infection. The award also recognizes related work surrounding gaining a new understanding of the structure and function of HIV’s capsid protein.
-
NewsNew study highlights efficiency in detecting infectious diseases
In an effort to make large-scale disease testing faster and more affordable, researchers have developed an optimized approach to pooled testing, which could transform public health screening for infectious diseases.
-
NewsStudy finds widening inequalities in child vaccination rates across England
Vaccine uptake was found to be consistently lower among children in areas of higher deprivation, while the number of children susceptible to measles at age 5 increased 20-fold in the most deprived areas.
-
NewsUpdated Hep B vaccine more effective for people with HIV
A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn’t respond to prior vaccination, according to an international study.
-
NewsAround 1 in 5 of the world’s under 50s living with genital herpes (HSV)
Around 1 in 5 of the world’s under 50s—846 million people—are living with genital herpes infection, and more than 200 million 15-49 year olds probably had at least one symptomatic outbreak of the infection in 2020, suggest the latest global estimates.
-
NewsControlling infectious disease between wildlife and livestock on shared rangeland
New research looks at the nexus of wildlife and livestock for solutions to zoonotic disease. It examines the ongoing threat of emerging pathogens that can necessitate prompt deployment of medical countermeasures for life-saving interventions.
-
NewsNew study highlights rise in severe Shigella infections among homeless patients in Vancouver
A recent study has uncovered an increase in severe multidrug-resistant (MDR) Shigella sonnei infections, particularly among people experiencing homelessness (PEH) in Vancouver, Canada.
-
NewsMutation could facilitate H5N1 bird flu virus infection and potential transmission in humans
A recent study reveals that a single mutation in the H5N1 bird flu virus that has recently infected dairy cows in the U.S. could enhance the virus’ ability to attach to human cells, potentially increasing the risk of passing from person to person.
-
NewsBacterial ‘biopesticide’ against malaria mosquitoes successful in early field tests
An experimental bacteria-derived biopesticide is highly effective in killing malaria-carrying mosquitoes, including those that have developed resistance to chemical pesticides, according to initial field tests.
-
NewsTherapeutic tool inhibits the proliferation of the SARS-CoV-2 virus that causes COVID-19
A study led by the University of Barcelona and the Spanish National Research Council’s Institute for Advanced Chemistry of Catalonia (IQAC - CSIC) presents a new therapeutic tool capable of inhibiting the proliferation of the SARS-CoV-2 virus that causes COVID-19. Source: University of Barcelona The experts Verònica Noé ...
-
NewsThe viral puzzle of why humans are susceptible to hepatitis B - but monkeys are not
Scientists collaborated to reveal the structural features of hepatitis B viral receptor homologue in macaques that restrict viral entry into their cells.